Delivery Order SPE2DB22D3102-SPE2DB24FL0DA
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,544,215 units of the pharmaceutical drug Phenazopyridine 100 mg tablets. The $1,792.17 firm fixed price Delivery Order was awarded on May 8, 2024 by the Defense Logistics Agency (DLA), with a completion date of May 9, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,572.37 firm-fixed-price delivery order is for the supply of 4,567,013,416 units of the drug PHENAZOPYRIDINE 200 MG TAB 100S. The contract has an ultimate completion date of January 23, 2025. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
- This federal contract award, valued at $1,070.61, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,563,829,141 units of the drug Phenazopyridine 200 mg, which is used to treat urinary tract infections. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of March 4, 2024. The award is not designated as a...
- This federal contract award, with the ID SPE2DX15D3504|SPE2DX24F00G7, is for the delivery of 4562494474 - Phenazopyridine 200mg Tablets in quantities of 100 to the U.S. government. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., on October 16, 2023 with a ceiling value of $1,585.70. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of October 17, 2023. The contracting agency is...
- This is a firm fixed price delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, the prime contractor. The contract, valued at $1,119.66, is for the supply of 100 mg tablets of the drug phenazopyridine in 100 count bottles. The delivery order has a period of performance through March 29, 2024 and is not associated with any set-aside designations. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which...
- This firm-fixed-price delivery order contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is valued at $6,062.54 and has an ultimate completion date of November 1, 2024. The award covers the delivery of Pyrazinamide 500 mg tablets to support federal healthcare programs. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,734.33 firm fixed-price delivery order is for the supply of Pyrazinamide tablets, with a period of performance through May 2025. The award is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical. This IDC provides a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The $1,440.36 fixed-price delivery order is for the supply of 4565053426 - Pyrazinamide 500 mg Tablets in 90-count packages. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 between Amerisourcebergen and the DLA Troop Support Medical, which serves as the primary vehicle for the...
- This federal contract award, with an ID of SPE2DB20D3103|SPE2DB25FL6F9, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,186.98, is a delivery order contract for the supply of 4,566,419,575 units of the drug Pioglitazone HCL 15 mg tablets. The contract has a firm fixed price pricing type and an ultimate completion date of November 14, 2024. AmerisourceBergen holds a...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,669.15, is a Firm Fixed Price Delivery Order for the supply of Pioglitazone HCL 45 MG Tablets. The contract has an ultimate completion date of February 7, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which...
- SPE2DB22D3102Indefinite Delivery Contract
- SPE2DB22D3102-SPE2DB24FL0DADelivery Order
This federal contract award, with ID SPE2DB22D3102|SPE2DB24FL0DA, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,330.71 firm fixed-price delivery order is for the supply of 4,563,744,487 units of the medication Phenazopyridine 100 mg tablets. The contract has an ultimate completion date of February 23, 2024. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as AmerisourceBergen. This contract award is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 2/22/24 |